WO2012158197A3 - Compounds useful as akt/pkb modulators and uses thereof - Google Patents
Compounds useful as akt/pkb modulators and uses thereof Download PDFInfo
- Publication number
- WO2012158197A3 WO2012158197A3 PCT/US2011/060467 US2011060467W WO2012158197A3 WO 2012158197 A3 WO2012158197 A3 WO 2012158197A3 US 2011060467 W US2011060467 W US 2011060467W WO 2012158197 A3 WO2012158197 A3 WO 2012158197A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- akt
- compounds useful
- pkb
- modulators
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compounds, and pharmaceutical compositions, and formulations thereof, are disclosed that have formula (I): where R1a, R1b, R1c, R2, R3, R6a, R6b, R6c, R7, and R8 are as defined herein. The compounds, pharmaceutical compositions, and pharmaceutical formulations thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cancer, and others. The manufacturing and analytical methods for LD- 101 are also disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41244810P | 2010-11-11 | 2010-11-11 | |
US61/412,448 | 2010-11-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012158197A2 WO2012158197A2 (en) | 2012-11-22 |
WO2012158197A3 true WO2012158197A3 (en) | 2013-03-14 |
Family
ID=47177531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/060467 WO2012158197A2 (en) | 2010-11-11 | 2011-11-11 | Compounds useful as akt/pkb modulators and uses thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012158197A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103044311B (en) * | 2012-12-26 | 2015-04-22 | 山东大学 | Multi-substituted indole compounds and preparation method and application thereof |
CN103399100A (en) * | 2013-08-13 | 2013-11-20 | 中国热带农业科学院农产品加工研究所 | Measuring method of vitamin E content in fruits |
WO2015097667A2 (en) * | 2013-12-23 | 2015-07-02 | Cellworks Group, Inc., | A composition, process of preparation of said composition, kit and a method of treating cancer |
CN115025097A (en) * | 2022-06-30 | 2022-09-09 | 四川大学 | Application of raltitrexed in preparation of medicine targeting CHMP3 gene |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3673184A (en) * | 1970-09-02 | 1972-06-27 | Dainippon Pharmaceutical Co | Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives |
US6331287B1 (en) * | 1995-08-23 | 2001-12-18 | University Advanced Bio-Imaging Associates | 2′-deoxy-2′-fluoro-d-arabinofuranosyl pyrimidine nucleoside |
WO2005113762A1 (en) * | 2004-05-18 | 2005-12-01 | Pfizer Products Inc. | CRYSTAL STRUCTURE OF PROTEIN KINASE B-α (AKT-1) AND USES THEREOF |
US7081449B2 (en) * | 2000-07-06 | 2006-07-25 | Valeant Research & Development | Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
WO2009009793A2 (en) * | 2007-07-12 | 2009-01-15 | University Of South Florida | Inhibitors of akt/pkb with anti-tumor activity |
US7678801B2 (en) * | 2005-03-25 | 2010-03-16 | Glaxo Group Limited | Compounds |
US20100261667A1 (en) * | 2001-11-27 | 2010-10-14 | Anadys Pharmaceuticals, Inc. | 3-ß-D-RIBOFURANOSYLTHIAZOLO[4-5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF |
-
2011
- 2011-11-11 WO PCT/US2011/060467 patent/WO2012158197A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3673184A (en) * | 1970-09-02 | 1972-06-27 | Dainippon Pharmaceutical Co | Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives |
US6331287B1 (en) * | 1995-08-23 | 2001-12-18 | University Advanced Bio-Imaging Associates | 2′-deoxy-2′-fluoro-d-arabinofuranosyl pyrimidine nucleoside |
US7081449B2 (en) * | 2000-07-06 | 2006-07-25 | Valeant Research & Development | Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
US20100261667A1 (en) * | 2001-11-27 | 2010-10-14 | Anadys Pharmaceuticals, Inc. | 3-ß-D-RIBOFURANOSYLTHIAZOLO[4-5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF |
WO2005113762A1 (en) * | 2004-05-18 | 2005-12-01 | Pfizer Products Inc. | CRYSTAL STRUCTURE OF PROTEIN KINASE B-α (AKT-1) AND USES THEREOF |
US7678801B2 (en) * | 2005-03-25 | 2010-03-16 | Glaxo Group Limited | Compounds |
WO2009009793A2 (en) * | 2007-07-12 | 2009-01-15 | University Of South Florida | Inhibitors of akt/pkb with anti-tumor activity |
Also Published As
Publication number | Publication date |
---|---|
WO2012158197A2 (en) | 2012-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009152356A3 (en) | Compounds and compositions useful for the treatment of malaria | |
WO2006102610A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
EP2086540B8 (en) | Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
WO2014007951A3 (en) | Substituted tricyclic compounds as fgfr inhibitors | |
WO2007109192A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2013036912A3 (en) | Amido compounds as rorϒtmodulators and uses thereof | |
WO2007109172A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2013163190A8 (en) | Dna-pk inhibitors | |
WO2009156462A3 (en) | Organic compounds | |
WO2012027728A3 (en) | Compositions and methods for targeted thermomodulation | |
WO2008070129A3 (en) | Compositions and methods for the treatment of inflammatory disease | |
WO2007109154A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2010058032A3 (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
WO2010111406A3 (en) | Purine derivatives useful as anti - cancer agents | |
WO2007109160A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2012074547A3 (en) | STEROID COMPOUNDS AS RORγt MODULATORS AND USES THEREOF | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2007109182A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2007109279A3 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
WO2012103810A1 (en) | Certain chemical entities, compositions, and methods | |
WO2008097924A3 (en) | Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders | |
WO2011123678A3 (en) | Substituted benzo-pyrido-triazolo-diazepine compounds | |
GB201213267D0 (en) | Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases | |
WO2011023367A3 (en) | Bisphosphonate-prodrugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11865643 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11865643 Country of ref document: EP Kind code of ref document: A2 |